←Endocrine
Inpatient hyperglycemia & insulin
📚
📚 Library › 🍬 Endocrine › Diabetes
💉

Inpatient hyperglycemia & insulin

Targets 140–180, basal-bolus math, NPO and steroid rules, tube feeds, and the discharge regimen.

insulinbasal-bolussliding scalesteroidshypoglycemia
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 ADA Standards of Care 2026 (Section 16) · Endocrine Society 2022 inpatient hyperglycemia guideline
🧠 Pathophysiology in 60 seconds🔎 Diagnosis💊 Management🏠 Discharge⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Target 140–180 mg/dL for most inpatients (100–180 in selected stable patients).
  • Sliding scale alone is not a plan. Use basal + nutritional (prandial) + correction (RABBIT-2).
  • Starting total daily dose (TDD): 0.3–0.5 U/kg (0.2–0.3 if age >70, eGFR <30, low weight); 50% basal, 50% prandial.
  • NPO → reduce basal by ~20–25%, stop prandial, keep correction.
  • Prednisone in the morning → NPH in the morning (0.1 U/kg per 10 mg prednisone, max 0.4 U/kg).
  • Every hypoglycemia (<70) → review and reduce the regimen the same day.

🧠 Pathophysiology in 60 seconds

⌄
  • Illness = stress hormones (cortisol, catecholamines, cytokines) → insulin resistance → hyperglycemia even without known diabetes ("stress hyperglycemia").
  • Hyperglycemia → infection, worse wound healing, longer stay. Hypoglycemia → arrhythmia, falls, death — just as harmful.
  • Insulin needs change daily (eating, steroids, infection improving) → adjust every day.

🔎 Diagnosis

⌄
  • Check A1c if none in the last 3 months (A1c ≥6.5% → diabetes; also guides discharge).
  • POC glucose: before meals + bedtime (eating) or q4–6h (NPO/continuous feeds).
  • Type 1 diabetes → always basal insulin, even NPO (risk of DKA).

💊 Management

⌄

Example: 80 kg, eating, eGFR normal → TDD 0.4 × 80 = 32 U - Basal: 16 U glargine daily - Prandial: 16 U ÷ 3 ≈ 5 U lispro with each meal (hold if eating <50%) - Correction: sensitive / usual / resistant scale with meals

Titrate basal by 10–20% every 1–2 days to fasting target.

Situation Plan
NPO Basal 75–80% of dose; correction q4–6h; no prandial
Continuous tube feeds Basal 40% of TDD + regular insulin q6h or NPH q8–12h for the feed; if feeds stop → start D10
Prednisone (AM) NPH with the steroid (0.1 U/kg per 10 mg prednisone, max 0.4 U/kg)
Dexamethasone Longer acting → basal (glargine) increase or NPH BID
Type 2, mild hyperglycemia, eating little Basal + correction (or DPP-4 inhibitor + correction in selected)
Insulin pump / CGM May continue if patient is alert and able, with policy
  • <70: 15–20 g fast carbs (or D50 25 mL IV if NPO/AMS, glucagon 1 mg IM if no IV) → recheck in 15 min.
  • Find why: missed meal with prandial given, renal decline, steroids tapered, sepsis.
  • Reduce the regimen 10–20% (or more).
  • Metformin: hold if contrast with AKI, eGFR <30, hypoxia, sepsis, liver failure.
  • SGLT2i: hold if NPO, acutely ill, or 3 days before surgery (euglycemic DKA).
  • GLP-1 RA: continue if eating; hold with vomiting/pancreatitis concerns.
  • Sulfonylureas: usually stop (hypoglycemia).

🏠 Discharge

⌄
A1c Plan
<8% Home regimen (or optimize)
8–10% Home oral agents + basal (~50% of inpatient basal)
>10% Basal-bolus or basal + GLP-1 RA / intensify
  • ☐ Glucometer, strips, pen needles, teaching (teach-back)
  • ☐ Hypoglycemia plan; check insurance coverage of insulin
  • ☐ SGLT2i/GLP-1 RA if ASCVD, HF, CKD
  • ☐ PCP/endocrine follow-up in 1–2 weeks

⚠️ Pitfalls

⌄
  • "Sliding scale only" for days.
  • Full prandial doses when the patient is not eating.
  • Missing the afternoon/evening spike from AM prednisone.
  • Stopping feeds without a dextrose plan → hypoglycemia.

🎓 Board corner

⌄
Stem Answer
Type 1 diabetes, NPO for surgery Continue basal (reduced), never stop
Glucose high only in afternoon on prednisone AM NPH
Inpatient target in non-critically ill 140–180
Hypoglycemia at 3 AM, fasting high Somogyi is rare — check basal dose and timing

📚 References

⌄
  • American Diabetes Association. Standards of Care in Diabetes—2026. Section 16: Diabetes Care in the Hospital. Diabetes Care. 2026;49(Suppl 1).
  • Korytkowski MT, et al. Endocrine Society Guideline: Management of Hyperglycemia in Hospitalized Adults. JCEM. 2022;107:2101.
  • Umpierrez GE, et al. RABBIT 2. Diabetes Care. 2007;30:2181.
↩︎ Back to 🍬 Endocrine